ResearcherConsejo Nacional de Investigaciones Científicas y TécnicasActive in the last 2 years
Carlos Alberto Davio
Matched on ORCID iD 0000-0002-4650-3784; OpenAlex author ID A5070230174. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 17
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers
Papers 6
- Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. Co-author DOI 10.1016/j.ijbiomac.2024.136386↗
- The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. Co-author DOI 10.3389/fphar.2024.1432851↗
- [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. First author PMID 37582144↗
- Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness. Last author DOI 10.1038/s41598-020-71181-w↗
- Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux. Last author DOI 10.1124/mol.118.115444↗
- Dual role of cAMP in the transcriptional regulation of multidrug resistance-associated protein 4 (MRP4) in pancreatic adenocarcinoma cell lines. Co-author DOI 10.1371/journal.pone.0120651↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ana Sahores · 5 shared papers, 2019–2024 · strength 0.75
- Paper Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. DOI 10.1016/j.ijbiomac.2024.136386↗
- Paper The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. DOI 10.3389/fphar.2024.1432851↗
- Paper [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. PMID 37582144↗
- Agustín Yaneff · 5 shared papers, 2019–2024 · strength 0.75
- Paper Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. DOI 10.1016/j.ijbiomac.2024.136386↗
- Paper The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. DOI 10.3389/fphar.2024.1432851↗
- Paper [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. PMID 37582144↗
- Betina González · 3 shared papers, 2023–2024 · strength 0.56
- Paper Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. DOI 10.1016/j.ijbiomac.2024.136386↗
- Paper The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. DOI 10.3389/fphar.2024.1432851↗
- Paper [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. PMID 37582144↗
- Nicolas Alejandro Fraunhoffer · 2 shared papers, 2023–2024 · strength 0.33
- Juan Iovanna · 2 shared papers, 2023–2024 · strength 0.33
- Nelson Dusetti · 2 shared papers, 2023–2024 · strength 0.33
- Alejandro Carozzo · 3 shared papers, 2015–2020 · strength 0.25
- Paper Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness. DOI 10.1038/s41598-020-71181-w↗
- Paper Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Mo… DOI 10.1124/mol.118.115444↗
- Paper Dual role of cAMP in the transcriptional regulation of multidrug resistance-associated protein 4 (MRP4) in pancreatic a… DOI 10.1371/journal.pone.0120651↗
- Ramiro Héctor Cerviño · 1 shared paper, 2024 · strength 0.23
- Samanta N. Gancedo · 1 shared paper, 2024 · strength 0.19
- Oscar Mazza · 1 shared paper, 2023 · strength 0.14
- María Eugenia Pasqualini · 1 shared paper, 2023 · strength 0.14
- María Noé Garcia · 1 shared paper, 2023 · strength 0.14
- Patricia Santofimia‐Castaño · 1 shared paper, 2023 · strength 0.14
- Eduardo Chuluyán · 1 shared paper, 2023 · strength 0.14
- Daniela Laura Papademetrio · 1 shared paper, 2023 · strength 0.14
- Daniel Grasso · 1 shared paper, 2023 · strength 0.14
- Natalia Fernández · 2 shared papers, 2015–2019 · strength 0.14
- Paper Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Mo… DOI 10.1124/mol.118.115444↗
- Paper Dual role of cAMP in the transcriptional regulation of multidrug resistance-associated protein 4 (MRP4) in pancreatic a… DOI 10.1371/journal.pone.0120651↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.